gsk2636771
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 25, 2016 (NCT04439149)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04439149 | Phase 2 | Feb 25, 2016 | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI) |
| NCT04439188 | Phase 2 | Feb 25, 2016 | ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ECOG-ACRIN Cancer Research Group | Academic/Hospital | 2 | 0 | 1 | 2016 |
| National Cancer Institute (NCI) | Government | 2 | 2 | 1 | 2016 |
2 organizations
Page 1 / 1